30 Mar 2026
Thiazole‐Semicarbazone Hybrids as Dual‐Stage Inhibitors of <i>Leishmania major</i> Growth: Design, Synthesis, and Mechanistic InsightsPublisher siteDrug Development Research, Research on Leishmaniasis Studies
Active, last published 2026
0
H-index
0
Citations
Moataz has not officially claimed their profile. If you are Moataz, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Moataz A. Shaldam will appear here once their profile is updated.
02 · Reach
Publication output and reach
Moataz's work has been cited 0 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchKafrelsheikh University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
14 works26 Mar 2026
Isatin-triazole/imidazole hybrids as dual CDK2/VEGFR2 inhibitors with potent anti-cancer activity: design, synthesis, and biological evaluationsPublisher siteBioorganic Chemistry, Cancer-related Molecular Pathways
7 Mar 2026
Design, synthesis, in vitro, and in silico evaluation of multi-functionalized pyrimidines as potential multitarget-directed anti-inflammatory agentsPublisher siteBioorganic Chemistry, Inflammatory mediators and NSAID effects
5 Mar 2026
Biphenyl urea derivatives as novel GPX4 inhibitors: ferroptosis-mediated antiproliferative activity against CNS cancer cellsPublisher siteBioorganic Chemistry, Ferroptosis and cancer prognosis
4 Mar 2026Open access
Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activityPublisher siteFrontiers in Pharmacology, Cancer therapeutics and mechanisms
21 Feb 2026Open access
Exploring the impact of the innovative compound 3-(3-(4-hydroxy-2-oxo-2H-chromen-3-yl)-5-(pyridin-3-yl)-1H-pyrazol-1-yl) indolin-2-one on accelerating wound recoveryPublisher siteScientific Reports, Wound Healing and Treatments
17 Feb 2026
Patents involving monoamine oxidase (MAO): a comprehensive update (2022–2025) on its inhibitors and applicationsPublisher siteExpert Opinion on Therapeutic Patents, Parkinson's Disease Mechanisms and Treatments
16 Jan 2026Open access
Antifungal activity of oily core PEGylated PLGA nanocapsules loaded with Penicillium oxalicum fungal extract: in vitro, in vivo, and in silico studyPublisher siteMicrobial Cell Factories, Nanocomposite Films for Food Packaging
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Moataz?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you